GeNOsys, Inc.(fka GNYS)

[DFLY]

SWEET NEWS imo..GeNOsys Develops New Nitric Oxide Producing ProductsMar 8, 2011 8:00:00 AM
Copyright Business Wire 2011


PROVO, Utah--(BUSINESS WIRE)-- GeNOsys, Inc. (OTCBB:GNYS) announced that it has developed a group of nitric oxide producing products for topical use. The products support blood flow and collagen growth to injured tissue and support the healing process. The products will be available as a cream, gel or wash, depending on the desired application. Several patents have been filed related to the products and the procedures for their use. A patent application has also been filed for a nitric oxide producing product which may be used as a hand sterilizer.

“These products provide GeNOsys a significantly shorter pathway to revenue than that which can be expected from sales of our generator and nitric oxide producing medium,” stated Mr. John W.R. Miller, Chairman of the Board of GeNOsys. “We are continuing work on the generator and expect to be able to provide you with updated information on that project in the near future. We have great expectations for the positive impact our generator will have for medical treatments. We expect the cash flow generated from our topical products will fund the commercialization of the generator. We are working to introduce these products into the marketplace at the earliest date possible and expect sales to be initiated no later than the third quarter of this year.”

About GeNOsys:

GeNOsys, Inc. (generated nitric oxide systems) is a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems. Nitric oxide gas will be one of the medical gases that will be generated along with various combinations of beneficial medical gases suitable for the control of human disease. Distribution will be accelerated through the use of already existing distribution networks that currently sell related respiratory products. The Company is currently working to establish distribution channels for its topical products. For further information, see the Company’s Website at: www.genosysusa.com.

This press release may contain forward-looking statements including the Company’s beliefs about its business prospects and future results of operations. These statements involve risks and uncertainties. Among the important additional factors that could cause actual results to differ materially from those forward-looking statements are risks associated with the overall economic environment, changes in anticipated earnings of the company and other factors detailed in the company’s filings with the SEC. In addition, the factors underlying Company forecasts are dynamic and subject to change and therefore those forecasts speak only as of the date they are given. The Company does not undertake to update them; however, it may choose from time to time to update them and if it should do so, it will disseminate the updates to the investing public.



GeNOsys, Inc.

Keith Merrell, 801-623-4751 801-623-4751

[e-mail]

Source: GeNOsys, Inc.


----------------------------------------------

GeNOsys
Inc.Keith Merrell
801-623-4751 801-623-4751 [e-mail]